Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Vasc Surg. 2013 Mar 13;58(2):412–419. doi: 10.1016/j.jvs.2013.01.010

Table 1.

Physiologic and anatomic high-risk variables and how they are defined by the Centers for Medicare and Medicaid Services, administrative data, and the National Surgical Quality Improvement Program Database

CMS Definitions Administrative Data NSQIP Definitions
Physiologic High Risk
 Age > 80 years Age > 80 years Age > 80 years
 Recent MI within 30 days ** 412 History of a non-Q wave or a Q wave MI within 6 months of surgery
 Unstable angina ** 411.1 Angina within 30 days of surgery
 CHF class III or IV ** 428 Newly diagnosed CHF or chronic CHF with new symptoms within 30 days of surgery
 LVEF < 30% Unavailable Unavailable
 Hemodialysis ** 585.3 – 585.9, 586, V42.0, V45.1 – V45.12, V56.0 – V56.32, V56.8 Acute or chronic renal failure requiring peritoneal dialysis, hemodialysis, hemofiltration, hemodiafiltration, or ultrafiltration within 2 weeks of surgery
 Severe pulmonary disease * ** 490 – 492.8, 493, 494 – 494.1, 495– 505, 506.4 Severe COPD ***
 CABG/valve repair within 30 days ** 36.11 – 36.16, 35 CABG/valve repair performed at the same time as CEA
Anatomic High Risk
 Contralateral ICA occlusion Unavailable Unavailable
 Restenosis after CEA Unavailable Unavailable
 Prior neck surgery Unavailable Unavailable
 Contralateral laryngeal nerve palsy Unavailable Unavailable
 History of neck irradiation Unavailable Unavailable
 High or Low lesion Unavailable Unavailable

CMS, Centers for Medicare and Medicaid Services; MI, myocardial infarction; CHF, congestive heart failure; LVEF, left ventricular ejection fraction; CABG, coronary artery bypass grafting; ICA, internal carotid artery; CEA, carotid endarterectomy; COPD, chronic obstruction pulmonary disease

*

Forced expiratory volume in 1 second (FEV1) < 30% of predicted or home oxygen

**

ICD-9-CM codes

***

Functional disability from COPD, hospitalization for treatment of COPD, chronic bronchodilator therapy, or an FEV1 < 75% of predicted